Raymond J. Bartoszek - Net Worth and Insider Trading

Raymond J. Bartoszek Net Worth

The estimated net worth of Raymond J. Bartoszek is at least $466,390 dollars as of 2024-06-18. Raymond J. Bartoszek is the Director of Kineta Inc and owns about 863,685 shares of Kineta Inc (KA) stock worth over $466,390. Details can be seen in Raymond J. Bartoszek's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Raymond J. Bartoszek has not made any transactions after 2023-12-06 and currently still holds the listed stock(s).

Transaction Summary of Raymond J. Bartoszek

To

Raymond J. Bartoszek Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond J. Bartoszek owns 2 companies in total, including Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KA) .

Click here to see the complete history of Raymond J. Bartoszek’s form 4 insider trades.

Insider Ownership Summary of Raymond J. Bartoszek

Ticker Comapny Transaction Date Type of Owner
YMTX Yumanity Therapeutics Inc 2022-12-16 director
KA Kineta Inc 2023-12-06 director

Raymond J. Bartoszek Latest Holdings Summary

Raymond J. Bartoszek currently owns a total of 1 stock. Raymond J. Bartoszek owns 863,685 shares of Kineta Inc (KA) as of December 6, 2023, with a value of $466,390.

Latest Holdings of Raymond J. Bartoszek

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KA Kineta Inc 2023-12-06 863,685 0.54 466,390

Holding Weightings of Raymond J. Bartoszek


Raymond J. Bartoszek Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond J. Bartoszek has made a total of 3 transactions in Kineta Inc (KA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Kineta Inc is the acquisition of 2,250 shares on December 6, 2023, which cost Raymond J. Bartoszek around $9,945.

Insider Trading History of Raymond J. Bartoszek

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond J. Bartoszek Trading Performance

GuruFocus tracks the stock performance after each of Raymond J. Bartoszek's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond J. Bartoszek is 17.01%. GuruFocus also compares Raymond J. Bartoszek's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond J. Bartoszek within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Raymond J. Bartoszek's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Raymond J. Bartoszek

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 25.41 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 26.61 LIMIT LIMIT LIMIT LIMIT LIMIT

Raymond J. Bartoszek Ownership Network

Ownership Network List of Raymond J. Bartoszek

No Data

Ownership Network Relation of Raymond J. Bartoszek

Insider Network Chart

Raymond J. Bartoszek Owned Company Details

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Raymond J. Bartoszek is the director of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Yumanity Therapeutics Inc Insider Transactions

No Available Data

Raymond J. Bartoszek Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond J. Bartoszek. You might contact Raymond J. Bartoszek via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.

Discussions on Raymond J. Bartoszek

No discussions yet.